Cochrane · systematic review · CD008424
Curcumin for maintenance of remission in ulcerative colitis
Garg, SK, Ahuja, V, Sankar, MJ, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library
GutAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Curcumin versus placebo for maintenance of remission in ulcerative colitis
Population: Maintenance of remission in ulcerative colitis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Relapse at 6 months Clinical Disease Activty Index more than 42 Curcumin vs placebo | RR 0.24 [0.05, 1.09] | 1 study · 89 participants | Low Downgraded: risk of bias, imprecision, indirectness, publication bias |
Relapse at 12 months Clinical Disease Activty Index more than 42 Curcumin vs placebo | RR 0.7 [0.35, 1.4] | 1 study · 89 participants | Low Downgraded: risk of bias, imprecision, indirectness, publication bias |
Clinical Activity Index at 6 months Clinical Disease Activty Index 2. Scale from: 0 to 12. Curcumin vs placebo | no estimate extracted | 1 study · 82 participants | Low Downgraded: risk of bias, imprecision, indirectness, publication bias |
Endoscopic Index at 6 months Endoscopic Index9. Scale from: 1 to 4. Curcumin vs placebo | no estimate extracted | 1 study · 82 participants | Low Downgraded: risk of bias, imprecision, indirectness, publication bias |